Ketogenic Diets and Hepatocellular Carcinoma

Area of Science:

• Oncology
• Metabolic Medicine
• Nutritional Science

Background:

• Hepatocellular carcinoma (HCC) is a prevalent liver cancer with a high fatality rate.
• The liver's role in glucose and lipid metabolism makes it a target for interventions like the ketogenic diet (KD).
• KD, a high-fat, low-carbohydrate diet, is being investigated for its anti-cancer properties.

Purpose of the Study:

• To explore the potential of the ketogenic diet (KD) as an intervention for hepatocellular carcinoma (HCC).
• To review the mechanisms by which KD may affect HCC progression.
• To identify areas for future research regarding KD in HCC management.

Main Methods:

• Review of existing literature on ketogenic diet and cancer metabolism.
• Analysis of KD's impact on blood glucose, insulin, and lipid metabolism in the context of HCC.
• Examination of KD's effects on gene expression (e.g., HMGCS2) and inflammatory factors.

Main Results:

• KD may reduce tumor energy supply by lowering blood glucose and insulin levels.
• KD can increase HMGCS2 expression and regulate lipid metabolism, potentially inhibiting HCC progression.
• Ketone bodies produced during KD may induce histone hyperacetylation and reduce inflammation, protecting hepatocytes.

Conclusions:

• The ketogenic diet presents a promising avenue for HCC intervention due to its metabolic effects.
• Further research is essential to determine the specific effects and safety of KD for HCC.
• Optimizing KD composition and exploring combination therapies are crucial for enhancing anti-cancer efficacy.